|
|
|
Insider
Information: |
Papadopoulos Stelios |
Relationship: |
Director, 10% Owner |
City: |
Gaithersburg |
State: |
MD |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
8 |
|
Direct
Shares |
4,592,501 |
|
Indirect Shares
|
4,643,486 |
|
|
Direct
Value |
$30,834,037 |
|
|
Indirect Value
|
$32,807,314 |
|
|
Total
Shares |
9,235,987 |
|
|
Total
Value |
$63,641,351 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
3
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
3
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-3.0
|
Percentage
Gain/Loss : |
0.0%
|
-55.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Genvec Inc |
GNVC |
Director |
2003-08-21 |
305,840 |
|
0 |
Premium* |
|
Anadys Pharmaceuticals Inc |
ANDS |
Director |
2007-09-14 |
814,206 |
2004-03-25 |
1,995,374 |
Premium* |
|
Sgx Pharmaceuticals, Inc. |
SGXP |
Director |
2006-02-06 |
35,930 |
2006-02-06 |
0 |
Premium* |
|
Biogen Idec Inc |
BIIB |
Director |
2022-06-15 |
10,095 |
2022-06-15 |
28,206 |
Premium* |
|
Exelixis Inc |
EXEL |
Director |
2023-06-01 |
1,260,329 |
2017-09-22 |
0 |
Premium* |
|
Bg Medicine, Inc. |
BGMD |
Director |
2013-01-30 |
1,187,713 |
2011-02-09 |
0 |
Premium* |
|
Regulus Therapeutics Inc. |
RGLS |
|
2024-03-14 |
978,388 |
2014-12-12 |
0 |
Premium* |
|
Eucrates Biomedical Acquisition ... |
EUCR |
Director, 10% Owner |
|
0 |
2020-11-24 |
2,619,906 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
83 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
GNVC |
Genvec Inc |
Director |
|
2003-08-21 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
305,840 |
|
- |
|
ANDS |
Anadys Pharmaceuticals In... |
Director |
|
2004-03-25 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
509,902 |
|
- |
|
ANDS |
Anadys Pharmaceuticals In... |
Director |
|
2004-03-25 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,995,374 |
|
- |
|
ANDS |
Anadys Pharmaceuticals In... |
Director |
|
2004-03-31 |
4 |
B |
$7.00 |
$980,000 |
D/D |
140,000 |
649,902 |
2.39 |
- |
|
SGXP |
Sgx Pharmaceuticals, Inc. |
officerTitle |
|
2006-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
35,930 |
35,930 |
|
- |
|
ANDS |
Anadys Pharmaceuticals In... |
Director |
|
2007-08-17 |
4 |
B |
$2.15 |
$83,826 |
D/D |
38,989 |
688,891 |
2.39 |
- |
|
ANDS |
Anadys Pharmaceuticals In... |
Director |
|
2007-08-31 |
4 |
B |
$2.22 |
$73,116 |
D/D |
32,913 |
721,804 |
2.39 |
- |
|
ANDS |
Anadys Pharmaceuticals In... |
Director |
|
2007-09-05 |
4 |
B |
$2.30 |
$205,466 |
D/D |
89,333 |
811,137 |
2.39 |
- |
|
ANDS |
Anadys Pharmaceuticals In... |
Director |
|
2007-09-06 |
4 |
B |
$2.30 |
$460 |
D/D |
200 |
811,337 |
2.31 |
- |
|
ANDS |
Anadys Pharmaceuticals In... |
Director |
|
2007-09-14 |
4 |
B |
$2.30 |
$6,599 |
D/D |
2,869 |
814,206 |
2.39 |
- |
|
BIIB |
Biogen Idec Inc |
Director |
|
2008-07-09 |
4 |
A |
$0.00 |
$0 |
D/D |
2,050 |
2,050 |
0 |
- |
|
EXEL |
Exelixis Inc |
Director |
|
2008-10-30 |
4 |
B |
$3.20 |
$968,828 |
D/D |
300,000 |
942,277 |
2.39 |
- |
|
BIIB |
Biogen Idec Inc |
Director |
|
2009-06-03 |
4 |
A |
$0.00 |
$0 |
D/D |
2,245 |
4,295 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
Director |
|
2010-06-09 |
4 |
A |
$0.00 |
$0 |
D/D |
5,735 |
10,030 |
0 |
- |
|
EXEL |
Exelixis Inc |
Director |
|
2010-08-24 |
4 |
B |
$3.00 |
$610,197 |
D/D |
200,000 |
1,143,956 |
2.39 |
- |
|
BGMD |
Bg Medicine, Inc. |
Director |
|
2011-02-09 |
4 |
B |
$7.00 |
$525,000 |
D/D |
75,000 |
450,734 |
2.39 |
- |
|
BGMD |
Bg Medicine, Inc. |
Director |
|
2011-02-09 |
4 |
A |
$0.00 |
$265,349 |
D/D |
375,734 |
375,734 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
Director |
|
2011-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
2,900 |
12,930 |
0 |
- |
|
BGMD |
Bg Medicine, Inc. |
Director |
|
2011-11-09 |
4 |
OE |
$0.90 |
$302,797 |
D/D |
336,441 |
787,175 |
0 |
- |
|
BGMD |
Bg Medicine, Inc. |
Director |
|
2011-11-29 |
4 |
S |
$4.01 |
$4,323 |
D/D |
(1,078) |
937,713 |
0 |
- |
|
BGMD |
Bg Medicine, Inc. |
Director |
|
2011-11-29 |
4 |
OE |
$0.02 |
$4,303 |
D/D |
151,616 |
937,742 |
0 |
- |
|
BGMD |
Bg Medicine, Inc. |
Director |
|
2013-01-30 |
4 |
B |
$2.00 |
$500,000 |
D/D |
250,000 |
1,187,713 |
2.39 |
- |
|
BIIB |
Biogen Idec Inc |
Director |
|
2013-03-11 |
4 |
OE |
$53.43 |
$2,727,463 |
D/D |
46,675 |
20,925 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
Director |
|
2013-03-11 |
4 |
AS |
$172.08 |
$8,040,003 |
D/D |
(46,675) |
14,950 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
Director |
|
2013-06-11 |
4 |
AS |
$219.62 |
$443,632 |
D/D |
(2,020) |
12,930 |
0 |
- |
|
83 Records found
|
|
Page 1 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|